MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Watch List: Layoffs of 10% or More, Strategic Corporate Review, Delisting, Regulatory, Financial and/or Legal Issues
Vor Biopharma Inc. (NASDAQ: VOR)
Finance & Acquisitions: Vor Biopharma
Parents
Vor Biopharma Inc. (NASDAQ: VOR)
Children
2019: Vor Biopharma Completes $42 Million Series A Financing Round to Advance Lead Cell Therapy Product Candidate for the Treatment of Acute Myeloid Leukemia
2020: RA Capital doubles down on Siddhartha Mukherjee’s vision for a new cell engineering approach, leading Vor’s $110M Series B – Endpoints News
2020: RA Capital Management led Vor’s Series B round, which included Fidelity Management & Research Company, Alexandria Venture Investments, the Pagliuca family investment office (co-chairman of Bain Capital0, and earlier investors 5AM Ventures, the investment arm of Johnson & Johnson (NYSE: JNJ), Osage University Partners, and founding backer PureTech
2020: Vor Nabs $110M to Spare Healthy Cells From Targeted Cancer Drugs
2021: Vor Biopharma Launches $150 Million IPO
2022: Vor Biopharma (VOR) Investor Presentation -Slideshow_ seekingalpha.com
Jumps
Key People: Vor Biopharma
Organization & Developments: Vor Biopharma